Roche offers $5.7 billion to buy gene firm Illumina
by on Jan.25, 2012, under Health and Fitness
(Reuters) – Roche Holding AG is offering $5.7 billion in cash to buy U.S. gene sequencing company Illumina Inc in an unfriendly takeover bid that marks a major play by the Swiss drugmaker into the gene technology field. Gene sequencing is central …
View full post on Yahoo! Health News
